Next Article in Journal
Tumor Microenvironment-Responsive Magnetic Nanofluid for Enhanced Tumor MRI and Tumor multi-treatments
Next Article in Special Issue
The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease
Previous Article in Journal
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro
Previous Article in Special Issue
Cooccurring Type 1 Diabetes Mellitus and Autoimmune Thyroiditis in a Girl with Craniofrontonasal Syndrome: Are EFNB1 Variants Associated with Autoimmunity?
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(2), 165; https://doi.org/10.3390/ph16020165
Action Date Notes Link
article xml file uploaded 23 January 2023 08:15 CET Original file -
article xml uploaded. 23 January 2023 08:15 CET Update https://www.mdpi.com/1424-8247/16/2/165/xml
article pdf uploaded. 23 January 2023 08:15 CET Version of Record https://www.mdpi.com/1424-8247/16/2/165/pdf
article html file updated 23 January 2023 08:17 CET Original file -
article html file updated 1 March 2023 11:03 CET Update -
article html file updated 8 March 2023 01:42 CET Update https://www.mdpi.com/1424-8247/16/2/165/html
Back to TopTop